Congressional negotiators have reached agreement on what Roll Call says is $8.3 billion in emergency spending to respond to the coronavirus emergency, and the House is expected to vote on it Wednesday. The Hill reports the number at $7.76 billion—the legislative language isn't yet available to determine the exact amount. Regardless, it's at least three times as much as the Trump administration initially asked for.
The sticking point keeping members working late into the night was Republican insistence that Democrats drop a provision that required testing, treatment, and the eventual vaccine for the disease be purchased by the government and made available without cost to the public. That, they said, would hurt the drug industry. As of press time, it's not absolutely clear how this was resolved, with the legislative language not yet available. But Republicans sources told Roll Call that they would accept a "fair and reasonable" standard to be applied to the cost of government purchases of drugs and equipment.
According to both papers, there's $300 million in the bill for the direct purchase of vaccines, therapeutics, and diagnostics. A Democratic source told one reporter that would help ensure Americans can get vaccine regardless of their ability to pay, and that the bill contains "assurances the [government] will only pay a fair and reasonable price."